Tavneos 10 mg, Hartkapseln
7680667720010
CH-66772
Kapseln
Associated product:
TAVNEOS caps 10 mg fl 30 pce
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
245.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Authorization holder
Vifor Fresenius Medical Care
9014 St. Gallen
Authorization information
- Swissmedic authorization number
- 66772
- Drug name
- Tavneos, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L04AJ05
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 19/09/2022
- Authorization expiration date
- 18/09/2027
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- TAVNEOS caps 10 mg fl 30 pce
- Description (DE)
- TAVNEOS Kaps 10 mg Fl 30 Stk
- Market launch
- 19/09/2022
- Narcotic (BTM)
- No
Other package sizes (1)
TAVNEOS caps 10 mg fl 180 pce
180 KAP
GTIN: 7680667720027